Porcine Vaccine Market Trends 2022 | Segmentation, Outlook, Industry Report to 2028

The Porcine Vaccine Market size is expected to grow at an annual average of 6% during 2021-2027. Vaccines are the most important disease prevention tool for both animals and humans. Vaccination is considered a boon in veterinary medicine to preserve animal welfare by avoiding the spread of many endemic diseases. Pig vaccines are clinically used to protect pigs from deadly diseases by improving pig health and protecting pigs from viruses, bacteria and other pathogens.

The following segmentation are covered in this report:

By Technology

• Inactivated Vaccines
• Live Attenuated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Others

By Target Disease

• Diarrhea
• Swine Influenza
• Arthritis
• Bordetella Rhinitis
• Porcine Reproductive and Respiratory Syndrome (PRRS)
• Porcine Circovirus Associated Disease (PCVAD)
• Other Target Diseases

Company Profile

• Bayer AG
• IDT Biologika GmbH
• HIPRA
• Ceva Sante Animale
• Elanco
• Arko Laboratories Ltd
• Intervet Inc.
• Merial
• Vetoquinol

Scope of the report

The research study analyses the Porcine Vaccine Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Porcine Vaccine Market Report

• What was the Porcine Vaccine Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Porcine Vaccine Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.